ArticleFrontiers in oncology2022

Outcomes of Hypofractionated Stereotactic Radiotherapy for Small and Moderate-Sized Brain Metastases: A Single-Institution Analysis.

Michael Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.